Hepatitis B virus DNA is subject to extensive editing by the human deaminase AP0BEC3C

Hepatology

Volumn 46, Issue 3, 2007, Pages 682-689

  Baumert, Thomas F ^a,b,c,d   Rösler, Christine ^a   Malim, Michael H ^e   Von Weizsäcker, Fritz ^a,f  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3C ENZYME; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; DEAMINASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN BINDING; VIROGENESIS; VIRUS GENOME; VIRUS REPLICATION;

BASE SEQUENCE; CYTIDINE DEAMINASE; DNA REPLICATION; DNA, VIRAL; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEOSIDE DEAMINASES; REPRESSOR PROTEINS; RIBONUCLEASES; RNA, VIRAL; VIRUS REPLICATION;

EID: 34548779664     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21733     Document Type: Article

References (31)

1. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004;350:1118-1129.
2. Lau JYN, Wright T. Clinical aspects of hepatitis B virus infection. Lancet 1993;342:1340-1344.
3. Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980;36:829-836.
4. Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U S A 1978;75:4533-4537.
5. Baumann JG. Intracellular restriction factors in mammalian cells - an ancient defense system finds a modern foe. Curr HIV Res 2006;4:141-168.
6. Simon JH, Gaddis NC, Fouchier RA, Malim MH. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 1998;4:1397-1400.
7. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-650.
8. Huthoff H, Malim MH. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins. Virology 2005;334:147-153.
9. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003;424:99-103.
10. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003;424:94-98.
11. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003;113:803-809.
12. Navarro F, Bollman B, Chen H, Konig R, Yu Q, Chiles K, et al. Complementary function of the two catalytic domains of APOBEC3G. Virology 2005;333:374-386.
13. Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, et al. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol 2005;15:166-170.
14. Le Pogam S, Chua PK, Newman M, Shih C. Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). J Virol 2005;79:1871-1887.
15. Khan MA, Kao S, Miyagi E, Takeuchi H, Goila-Gaur R, Opi S, et al. Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J Virol 2005;79:5870-5874.
16. Mangeat B, Turelli P, Liao S, Trono D. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J Biol Chem 2004;279:14481-14483.
17. Rösler C, Köck J, Malim MH, Blum HE, von Weizsäcker F. Comment on "Inhibition of hepatitis B virus replication by APOBEC3G". Science 2004;305:1403.
18. Rösler C, Kock J, Kann M, Malim MH, Blum HE, Baumert TF, et al. APOBEC-mediated interference with hepadnavirus production. HEPATOLOGY 2005;42:301-309.
19. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 2004;4:868-877.
20. Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. HEPATOLOGY 2006;43:1364-1374.
21. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci U S A 2005;102:8321-8326.
22. Reifenberg K, Nusser P, Lohler J, Spindler G, Kuhn C, von Weizsäcker F, et al. Virus replication and virion export in X-deficient hepatitis B virus transgenic mice. J Gen Virol 2002;83:991-996.
23. Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 1990;64:613-620.
24. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992;66:4107-4116.
25. Baumert TF, Marrone A, Vergalla J, Liang TJ. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol 1998;72:6785-6795.
26. Blum HE, Galun E, Liang TJ, von Weizsäcker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991;65:1836-1842.
27. Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology 1999;42:100-116.
28. Svarovskaia ES, Xu H, Mbisa JL, Barr R, Gorelick RJ, Ono A, et al. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem 2004;279:35822-35828.
29. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004;303:1829.
30. Cullen B. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol 2006;80:1067-1076.
31. Gunther S, Sommer G, Plikat U, Iwanska A, Wain-Hobson S, Will H, et al. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G → A hypermutation. Virology 1997;235:104-108.